AMIIF Advances Mexico’s Healthcare Through Pharma Innovation

Mexico’s pharmaceutical industry has been instrumental in transforming healthcare, advancing scientific research, and enhancing patient outcomes, reports the Mexican Association of Research-Based Pharmaceutical Industries (AMIIF). At AMIIF’s 10th Innovation Week, industry leaders and government officials emphasized that continuous innovation and strategic collaboration are vital to addressing the country’s evolving health challenges.

“We have witnessed how pharmaceutical innovation has transformed diseases that were once considered a fatal sentence into manageable conditions that improve patients’ quality of life," says David Kershenobich, Minister of Health.

During the event, Kershenobich highlighted the government’s commitment to building a health system characterized by quality, safety, and efficiency, supported by robust regulatory frameworks, visionary public policies, and the protection of intellectual property. He also underscored the importance of ongoing dialogue between health authorities and the pharmaceutical industry to ensure timely access to quality medicines and advance economic development.

Francisco Cervantes, President, Business Coordinating Council (CCE), highlighted Mexico’s emergence as a regional pharmaceutical hub, now the second-largest producer in Latin America and the eighth-largest global exporter of medical devices. Cervantes also recognized the vital role of multinational companies in leveraging Mexican talent and fostering scientific advancement.

“Together, through harmonious alliances with other productive sectors, educational institutions, and the government, we have built a backbone pharmaceutical sector that serves as a model for Mexican companies,” says Cervantes.

However, the sector faces pressing challenges, including an aging population, regulatory delays, and gaps in access to innovative therapies, says Jorge Luis Caridad, Director General, Johnson & Johnson Innovative Medicine Mexico. He stressed that public-private partnerships are no longer optional but essential to overcoming these challenges sustainably. 

“It is very important to share a common vision that health is not an expense. Health is an investment. It is an investment in the development of our country,” says Caridad.

As AMIIF celebrates 75 years of dedication and excellence, the Innovation Week reaffirmed the shared commitment among stakeholders to strengthen Mexico’s health ecosystem. Through strategic partnerships, innovation, and effective communication, the industry and its allies aim to build a more resilient, equitable, and forward-looking healthcare system that meets the evolving needs of all Mexicans.